awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26750649-D8A912B1-157D-4658-9AB8-2547C12C0C18
Q26750649-D8A912B1-157D-4658-9AB8-2547C12C0C18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750649-D8A912B1-157D-4658-9AB8-2547C12C0C18
Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments
P2860
Q26750649-D8A912B1-157D-4658-9AB8-2547C12C0C18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750649-D8A912B1-157D-4658-9AB8-2547C12C0C18
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7842c5dc7088d027285c1eb0cd33dff4def6e2d
P2860
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.